VitalyMargulisMD

Minimally Invasive Surgery, Surgical Oncology

Professor of Urology, University of Texas Southwestern Medical Center, Southwestern Medical School

Dr. Margulis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5323 Harry Hines Blvd
Stop 9110
Dallas, TX 75390
Phone+1 214-648-0567

Fax+1 214-648-8786

Dr. Vitaly Margulis is an urologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Children's Medical Center Dallas, Veterans Affairs North Texas Health Care System, and University of Texas Southwestern Medical Center. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 16 years. He also speaks multiple languages, including Spanish, French, Russian, and Ukrainian. He specializes in minimally invasive surgery and surgical oncology and is experienced in prostatitis, urologic oncology, minimally invasive urologic surgery, penile cancer, and bladder.

University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2009
University of Texas Health Science Center at HoustonResidency, Urology, 2006 - 2008
University of Texas Southwestern Medical CenterResidency, Urology, 2001 - 2006
University of Texas Southwestern Medical CenterInternship, Urology, 2001 - 2002
University of Texas Southwestern Medical SchoolClass of 2001

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons
Join now to see all

PubMed

22 citations
Dysregulation of β-Catenin is an Independent Predictor of Oncologic Outcomes in Patients with Clear Cell Renal Cell Carcinoma
Laura Maria Krabbe, Mary E. Westerman, Aditya Bagrodia, Bishoy A. Gayed, Oussama M. Darwish
The Journal of Urology. 2014-06-01
121 citations
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
Vitaly Margulis, Shahrokh F. Shariat, Raheela Ashfaq, Arthur I. Sagalowsky, Yair Lotan
Clinical Cancer Research. 2006-12-15
702 citations
BAP1 loss defines a new class of renal cell carcinoma
Samuel Peña-Llopis, Silvia Vega-Rubin-de-Celis, Arnold Liao, Nan Leng, Andrea Pavia-Jimenez
Nature Genetics. 2012-07-01

Lectures

Pathologic response and surgical outcomes in patients undergoing nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma.
2019 ASCO Annual Meeting - 6/1/2019

Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018

Children’s Research Institute at UT Southwestern Scientists Discover Kidney Cancers Rely on Mitochondrial Metabolism to MetastasizeAugust 14th, 2024
UT Southwestern Investigators Report First Analysis of Pioneering Kidney Cancer Radiation Approach in Clinical TrialJune 24th, 2021
UT Southwestern-Led Researchers Find New Way to Determine Prognosis of Invasive Kidney CancerMay 24th, 2018
Join now to see all